Summary & Overview
HCPCS Level II C1737: Sacroiliac and Pelvic Joint Fusion Implantable Device
HCPCS Level II code C1737 designates an implantable joint fusion and fixation system for the sacroiliac joint and pelvis, encompassing all system components. The code is relevant to surgical episodes involving sacroiliac fusion — a growing area of spine and pelvic orthopedic practice — and affects device procurement, hospital supply management, and payer coverage decisions nationwide. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of clinical context for sacroiliac fusion devices, common sites of service where C1737 is used, and where this HCPCS Level II code fits in procedure and device billing workflows. The publication summarizes payer coverage patterns, coding and billing considerations, and benchmark-oriented metrics where available. Policy updates and reimbursement-related guidance at the national level are highlighted to inform billing, coding, and revenue cycle teams. The content is intended to support administrators, coders, and clinicians in understanding how C1737 is classified and used in claims for implantable sacroiliac and pelvic fusion systems.
Billing Code Overview
HCPCS Level II code C1737 represents joint fusion and fixation device(s), sacroiliac and pelvis, including all system components (implantable). This device code covers implantable systems used to achieve fusion and provide fixation for the sacroiliac joint and pelvic bones.
Service type: implantable orthopedic device for sacroiliac/pelvic fusion.
Typical site of service: inpatient or outpatient surgical settings, including hospital operating rooms and ambulatory surgery centers, where orthopedic or spine surgeons perform sacroiliac joint fusion procedures.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 54-year-old patient with chronic low back and buttock pain refractory to conservative measures (physical therapy, oral analgesics, and image-guided sacroiliac joint injections) presents for surgical stabilization. Imaging (CT and MRI) demonstrates sacroiliac joint degeneration with joint instability and pain provocation tests correlate clinically. The orthopedic spine surgeon schedules a sacroiliac joint fusion using implantable fixation devices designed for sacroiliac and pelvic fusion. Typical workflow: preoperative evaluation with medical clearance and informed consent; pre-op antibiotic prophylaxis; intraoperative fluoroscopic guidance for device placement; implantation of C1737 devices (including screws, cages, connectors and instrumentation as part of the system); intraoperative monitoring as indicated; postoperative recovery with pain control, wound care instructions, and a structured rehabilitation plan. Typical site of service is an inpatient or ambulatory surgery center (hospital outpatient or ASC) depending on patient comorbidity and payer authorization. Postoperative follow-up includes wound check, radiographic confirmation of hardware position, and progressive weight-bearing guidance.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work or complexity substantially exceeds typical for sacroiliac fusion and documentation supports additional work. |